Science
She’s Trying to Stay Ahead of Alzheimer’s, in a Race to the Death
Soon, Irene Mekel will need to pick the day she dies.
She’s not in any hurry: She quite likes her life, in a trim, airy house in Castricum, a Dutch village by the sea. She has flowers growing in her back garden, and there is a street market nearby where vendors greet villagers by name. But if her life is going to end the way she wants, she will have to pick a date, sooner than she might like.
“It’s a tragedy,” she said.
Ms. Mekel, 82, has Alzheimer’s disease. It was diagnosed a year ago. She knows her cognitive function is slowly declining, and she knows what is coming. She spent years working as a nurse, and she cared for her sister, who had vascular dementia. For now, she is managing, with help from her three children and a big screen in the corner of the living room that they update remotely to remind her of the date and any appointments.
In the not-so-distant future, it will no longer be safe for her to stay at home alone. She had a bad fall and broke her elbow in August. She does not feel she can live with her children, who are busy with careers and children of their own. She is determined that she will never move to a nursing home, which she considers an intolerable loss of dignity. As a Dutch citizen, she is entitled by law to request that a doctor help her end her life when she reaches a point of unbearable suffering. And so she has applied for a medically assisted death.
In 2023, shortly before her diagnosis, Ms. Mekel joined a workshop organized by the Dutch Association for Voluntary End of Life. There, she learned how to draft an advance request document that would lay out her wishes, including the conditions under which she would request what is called euthanasia in the Netherlands. She decided it would be when she could not recognize her children and grandchildren, hold a conversation or live in her own home.
But when Ms. Mekel’s family doctor read the advance directive, she said that while she supported euthanasia, she could not provide it. She will not do it for someone who has by definition lost the capacity to consent.
A rapidly growing number of countries around the world, from Ecuador to Germany, are legalizing medical assistance in dying. But in most of those countries, the procedure is available only to people with terminal illness.
The Netherlands is one of just four countries (plus the Canadian province of Quebec) that permit medically assisted death by advance request for people with dementia. But the idea is gaining support in other countries, as populations age and medical interventions mean more people live long enough to experience cognitive decline.
The Dutch public strongly supports the right to an assisted death for people with dementia. Yet most Dutch doctors refuse to provide it. They find that the moral burden of ending the life of someone who no longer has the cognitive capacity to confirm their wishes is too weighty to bear.
Ms. Mekel’s doctor referred her to the Euthanasia Expertise Center, in The Hague, an organization that trains doctors and nurses to provide euthanasia within the parameters of Dutch law and connects patients with a medical team that will investigate a request and provide assisted death to eligible patients in cases where their own doctors won’t. But even these doctors are reluctant to act after a person has lost mental capacity.
Last year, a doctor and a nurse from the center came every three months to meet with Ms. Mekel over tea. Ostensibly, they came to discuss her wishes for the end of her life. But Ms. Mekel knew they were really monitoring how quickly her mental faculties had declined. It might seem like a tea party, she said, “but I see them watching me.”
Dr. Bert Keizer is alert for a very particular moment: It is known as “five to 12” — five minutes to midnight. Doctors, patients and their caregivers engage in a delicate negotiation to time death for the last moment before a person loses that capacity to clearly state a rational wish to die. He will fulfill Ms. Mekel’s request to end her life only while she still is fully aware of what she is asking.
They must act before dementia has tricked her, as it has so many of his other patients, into thinking her mind is just fine.
“This balance is something so hard to discover,” he said, “because you as a doctor and she as your patient, neither of you quite knows what the prognosis is, how things will develop — and so the harrowing aspect of this whole thing is looking for the right time for the horrible thing.”
Ms. Mekel finds this negotiation deeply frustrating: The process does not allow for the idea that simply having to accept care can be considered a form of suffering, that worrying about what lies ahead is suffering, that loss of dignity is suffering. Whose assessment should carry more weight, she asks: current Irene Mekel, who sees loss of autonomy as unbearable, or future Irene, with advanced dementia, who is no longer unhappy, or can no longer convey that she’s unhappy, if someone must feed and dress her.
More than 500,000 of the 18 million people in the Netherlands have advance request documents like hers on file with their family doctors, explicitly laying out their wishes for physician-assisted death should they decline cognitively to a point they identify as intolerable. Most assume that an advance request will allow them to progress into dementia and have their spouses, children or caregivers choose the moment when their lives should end.
Yet of the 9,000 physician-assisted deaths in the Netherlands each year, just six or seven are for people who have lost mental capacity. The overwhelming majority are for people with terminal illnesses, mostly cancer, with a smaller number for people who have other nonterminal conditions that cause acute suffering — such as neurodegenerative disease or intractable depression.
Physicians, who were the primary drivers of the creation of the Dutch assisted dying law — not Parliament, or a constitutional court case, as in most other countries where the procedure is legal — have strong views about what they will and will not do. “Five to 12” is the pragmatic compromise that has emerged in the 23 years since the criminal code was amended to permit physicians to end lives in situations of “unbearable and irremediable suffering.”
A Shock
Ms. Mekel, petite and brisk, had suspected for some time before she received a diagnosis that she had Alzheimer’s. There were small, disquieting signs, and then one big one, when she took a taxi home one day and could not recognize a single house on the street where she had lived for 45 years, could not identify her own front door.
At that point, she knew it was time to start making plans.
She and her best friend, Jean, talked often about how they dreaded the idea of a nursing home, of needing someone to dress them, get them out of bed in the morning, of having their worlds shrink to a sunroom at the end of a ward.
“When you lose your own will, and you are no longer independent — for me, that’s my nightmare,” she said. “I would kill myself, I think.”
She knows how cognition can slip away almost imperceptibly, like mist over a garden on a spring morning. But the news that she would need to ask Dr. Keizer to end her life before such losses happened came as a shock.
Her distress at the accelerated timeline is not an uncommon response.
Dr. Pieter Stigter, a geriatric specialist who works in nursing homes and also as a consultant for the Expertise Center, must frequently explain to startled patients that their carefully drawn-up advance directives are basically meaningless.
“The first thing I tell them is, ‘I’m sorry, that’s not going to happen,’” he said. “Assisted dying while mentally incompetent, it’s not going to happen. So now we’re going to talk about how we’re going to avoid getting there.”
Patients who have cared for their own parents with dementia may specify in their advance directive that they do not wish to reach the point of being bedridden, incontinent or unable to feed themselves. “But still then, if someone is accepting it, patiently smiling, it’s going to be very hard to be convinced in that moment that even though someone described it in an earlier stage, that in that moment it is unbearable suffering,” Dr. Stigter said.
The first line people write in a directive is always, “‘If I get to the point I do not recognize my children,’” he said. “But what is recognition? Is it knowing someone’s name, or is it having a big smile when someone enters your room?”
Five-to-12 makes the burden being placed on physicians morally tolerable.
“As a doctor, you are the one who has to do it,” said Dr. Stigter, a warm and wiry 44-year-old. “I’m the one doing it. It has to feel good for me.”
Conversations about advance requests for assisted death in the Netherlands are shadowed by what many people who work in this field refer to, with a wince, as “the coffee case.”
In 2016, a doctor who provided an assisted death to a 74-year-old woman with dementia was charged with violating the euthanasia law. The woman had written an advance directive four years earlier, saying she wished to die before she needed to enter a care home. On the day her family chose, her doctor gave her a sedative in coffee, and then injected a stronger dose. But during the administration of the medication that would stop her heart, the woman awoke and resisted. Her husband and children had to hold her down so the doctor could complete the procedure.
The doctor was acquitted in 2019. The judge said the patient’s advance request was sufficient basis for the doctor to act. But the public recoil at the idea of the woman’s family holding her down while she died redoubled the determination of Dutch doctors to avoid such a situation.
A Day Too Late
Dr. Stigter never takes on a case assuming he will provide an assisted death. Cognitive decline is a fluid thing, he said, and so is a person’s sense of what is tolerable.
“The goal is an outcome that reflects what the patient wants — that can evolve all the time,” he said. “Someone can say, ‘I want euthanasia in the future’, but actually when the moment is there, it’s different.”
Dr. Stigter found himself explaining this to Henk Zuidema a few years ago. Mr. Zuidema, a tile setter, had early-onset Alzheimer’s at 57. He was told he would no longer be permitted to drive, and so he would have to stop working and give up his main hobby, driving a vintage motocross bike with friends.
A gruff, stoic family man, Mr. Zuidema was appalled at the idea of no longer providing for his wife or caring for his family, and he told them he would seek a medically assisted death before the disease left him totally dependent.
His own family doctor was not willing to help him die, nor was anyone in her practice, and so his daughter Froukje Zuidema found the Expertise Center. Dr. Stigter was assigned to his case and began driving 30 minutes from his office in the city of Groningen every month to visit Mr. Zuidema at his home in the farming village of Boelenslaan.
“Pieter was very clear: ‘You have to tell me when,’” Ms. Zuidema said. “And that was very hard, because Dad had to make the decision.”
When he grasped that the disease might impair his judgment, and thus cause him to overestimate his mental competence, Mr. Zuidema quickly settled on a plan to die within months. His family was shocked, but for him the trade-off was clear: “Better a year too early than a day too late,” he would say.
Dr. Stigter pushed Mr. Zuidema to define what, exactly, his suffering would be. “He would say, ‘Why is it so bad to get old like that?’” Ms. Zuidema recalled. “‘Why is it so bad to go to a nursing home?’” She said the doctor would tell her father, “ ‘Your idea of suffering is not the same as mine, so help me understand why this is suffering, for you.’ “
Her reticent father struggled to explain, and finally put it in a letter: “I don’t want to lose my role as a husband and a father, I do not want to be unable to help people any longer … Suffering would be if I could no longer be alone with my grandchildren because people did not trust me any longer: even this thought makes me crazy … Do not be misled by a moment in which I look happy but instead look back at this moment when I am with my wife and children.’”
The progress of dementia is unpredictable, and Mr. Zuidema did not experience a rapid decline. In the end, Dr. Stigter visited each month for a year and a half, and the two men developed a relationship of trust, Ms. Zuidema said.
Dr. Stigter provided a medically assisted death in September 2022. Mr. Zuidema, then 59, was in a camp bed near the living room window, his wife and children at his side. His daughter said she sees Dr. Stigter “as a real hero.” She has no doubt her father would have died by suicide even sooner, had he not been confident he could receive an assisted death from his doctor.
Still, she is wistful about the time they didn’t have. If the advance directive had worked as defined in the law — if there had been no fear of missing the moment — her father might have had more months, more time sitting on the vast green lawn between their houses and watching his grandchildren kick a soccer ball, more time with his dog at his feet, more time sitting on a riverbank with his grandson and a lazy fishing line in the water.
“He would have stayed longer,” Ms. Zuidema said.
Her sense that her father’s death was rushed does not outweigh her gratitude that he had the death he wanted. And her feeling is widely shared among families, according to research by Dr. Agnes van der Heide, a professor of end-of-life care and decision making at Erasmus Medical College, University Medical Center Rotterdam.
“The large majority of the Dutch population feel safe in the hands of the doctor, with regards to euthanasia, and they very much appreciate that the doctor has a significant role there and independently judges whether or not they think that ending of life is justifiable,” she said.
For five to 12 to work, doctors should know their patients well and have time to track changes in their cognition. As the public health system in the Netherlands is increasingly strained, and short of family practitioners, that model of care is becoming less common.
Ms. Mekel’s physician, Dr. Keizer, said his lengthy visits to patients were possible only because he is mostly retired and not in a hurry. (In addition to his half-time practice, he writes regular op-eds for Dutch newspapers and comments on high-profile cases. He is a bit of an assisted-dying celebrity, and, Ms. Mekel confided, the other older women at the right-to-die workshops were envious when they learned that he had been assigned as her physician.)
Now that he is clear on her wishes, the tea parties are paused; he will resume the visits when her children tell him there has been a significant change in her awareness or ability to function — when they feel that five to 12 is close.
An Intolerable Price
Ms. Mekel is haunted by what happened to her best friend, Jean, who, she said, “missed the moment” for an assisted death.
Although Jean was determined to avoid moving to a nursing home, she lived in one for eight years. Ms. Mekel visited her there until Jean became unable to carry on a conversation. Ms. Mekel continued to call her and sent emails that Jean’s children read to her. Jean died in the nursing home in July, at 87.
Jean is the reason Ms. Mekel is willing to plan her death for sooner than she might like.
Yet Jean’s son, Jos Van Ommeren, is not sure that Ms. Mekel understands her friend’s fate correctly. He agrees that his mother dreaded the nursing home, but once she got there, she had some good years, he said. She was a voracious reader and devoured a book from the residence library each day. She had loved sunbathing all her life, and the staff made sure she could sit in the sun and read for hours.
Most of the last years were good years, Mr. Van Ommeren said, and to have those, it was worth the price of giving up the assisted death she had requested.
For Ms. Mekel, that price is intolerable.
Her youngest son, Melchior, asked her gently, not long ago, if a nursing home might be OK, if by the time she got there she wasn’t so aware of her lost independence.
Ms. Mekel shot him a look of affectionate disgust.
“No,” she said. “No. It wouldn’t.”
Veerle Schyns contributed reporting from Amsterdam.
Audio produced by Tally Abecassis.
Science
Here’s why the Lincoln Memorial Reflecting Pool went green so fast
Just days after the Trump administration completed millions of dollars in renovations on the Lincoln Memorial Reflecting Pool to make it American flag-blue, residents and online users noted it had turned a phosphorescent green.
Here’s why:
The calm, still waters of the Reflecting Pool make it an ideal nursery for algae growth. Algae need nitrogen and phosphorus to grow, and the Reflecting Pool is primarily fed by the Potomac River, which gets heavy doses of those nutrients from nearby urban and agricultural lands.
The Potomac also absorbed one of the largest sewage spills in U.S. history earlier this year when a pipe burst five miles upstream of Washington, although that event probably happened too long ago to contribute to the algal bloom today.
Untreated sewage is high in nitrogen and phosphorus. When nutrient levels are high, feasting algae can quickly reproduce.
The Department of the Interior said when the algae first appeared that it was “residual,” from the supply lines to the pool.
Experts also speculate that the darker blue color may be helping the Reflecting Pool absorb more heat. The higher temperatures promote algae growth by allowing their metabolisms to shift into overdrive.
Summer temperatures in D.C. aren’t helping. This week, temperatures are as high as 95 degrees in the city, prompting a heat alert.
The combination probably explains the excessive growth, turning the water surface an opaque green and preventing onlookers from seeing the new blue hue of the concrete basin.
Algae are important and beneficial organisms when the ecosystem is in balance. They’re the base of the aquatic food chain, fed on by herbivores of all shapes and sizes, including shrimp and juvenile fish, which in turn feed organisms higher up the food chain. The single-celled organisms use the power of the sun to produce energy through photosynthesis, similar to houseplants on your balcony.
In an effort combat the algae in the Reflecting Pool, employees of the National Park Service were seen pouring in gallons of hydrogen peroxide, a chemical commonly used in pool maintenance.
The Department of the Interior also is employing a “high-tech nanobubble ozone technology” to destroy the cells of the algae.
Ozone — yes, the same irritant that is in smog — is a gas composed of three oxygen molecules, and the small size of the bubbles allow the most gas transfer into the water, where it can damage algal cells, similar to how it irritates our lungs.
This only treats the symptoms, however. Generally, ozone nanobubbling is effective as a temporary solution for algae blooms. Longer-term fixes would have to address what makes the Reflecting Pool so ideal for algae, such as its depth, darker color and inflow of nitrogen and phosphorus.
In California, ozone nanobubbles also have been used in a project to improve water quality in the Tijuana River. The 120-mile river that runs near the border in northern Mexico and Southern California was the site of a pilot study in 2025. The U.S. section of the International Boundary and Water Commission reported that the nanobubbling reduced “odors and bacteria,” but the project concluded prematurely after a flood swept some of the instrumentation into the river.
Science
This plant extract can make a lethal drug cocktail. Can it also treat opioid addiction?
A plant extract that’s gaining popularity as a pain cure-all and has been associated with multiple California deaths in its concentrated, synthetic form has been approved for research as a treatment for opioid addiction by the federal government.
Kratom is derived from the leaves of Mitragyna speciosa, a tree native to Southeast Asia, and is commonly made into a powder or pill.
Researchers say people in the U.S. are using kratom to alleviate anxiety, treat chronic pain or as a remedy for the symptoms associated with quitting opioids, due to its ability to bind with opioid receptors in the body. But recently, public health officials have raised alarms about a component of the leaf called 7-hydroxymitragynine, also known as 7-OH, an alkaloid that has the potential for abuse and addiction in high doses.
Last year, the Los Angeles County Public Health Department linked the deaths of six county residents to the use of 7-OH mixed with other substances. The toxicology screens for some of the deceased revealed both kratom and 7-OH, leading to a countywide crackdown of products with either compound because they’re unregulated.
Although there is no scientific consensus on whether kratom has therapeutic value, the Food and Drug Administration has recommended that its potent 7-OH form be classified as a controlled substance. Consumers who use 7-OH as a pain reliever expecting an experience similar to consuming kratom are at risk, said Dr. Mason Turner, president-elect of the California Society of Addiction Medicine.
“I have a couple of patients that I work with who use 7-OH for chronic pain management, not realizing the potential of the medication, and then developed an opioid use disorder,” Turner said. “I think in that case it was very clear they were seeking it for the chronic pain, not to get high, not to have some kind of experience, but really to reduce their pain.”
About two decades ago, Turner said, the healthcare industry started acknowledging the limits and risks of prescribing opioids for chronic pain. Some doctors pulled back on prescriptions, recognizing the potential for abuse.
That led some patients to find alternative solutions, he said.
“Maybe they don’t get a good benefit, or maybe the benefit from some of the other treatments is not as robust as what they got from opioids,” Turner said. “So they seek out some of these illicit products … or they look for kratom or 7-OH to be able to mitigate the pain.”
Turner said he supports further research into kratom and regulation because “it could be worth exploring as a treatment for chronic pain.”
On June 1, the National Institutes of Health announced that researchers from the University of Florida would begin the first phase of clinical trials on kratom to evaluate it as a potential treatment for opioid addiction. The research would be done with the FDA’s approval, according to officials.
“This … is a major step toward expanding treatment options for the millions of Americans struggling with opioid use disorder, which has contributed to historically high overdose mortality rates,” said Dr. Nora Volkow, director of NIH’s National Institute on Drug Abuse, in a statement.
Interest in kratom surged in the last couple of years as users have reported consuming the compound in the form of a pill, powder or tea to treat various ailments. A John Hopkins survey conducted in 2020 reported that 91% of respondents used kratom to treat chronic pain, 67% to treat anxiety, 64% for depression and 41% to treat opioid dependence.
A more recent study by the University of Michigan and Texas State University found that more than 5 million people in the U.S., including more than 100,000 children ages 12 to 17, have used kratom, the compound experts say is growing in popularity with young adults.
In the study, which analyzed data from the National Survey on Drug Use and Health collected between 2021 and 2024, researchers say that despite numerous state-level bans on kratom across the nation, its use is at an all-time high and is increasing.
People between the ages of 21 and 34 said they used kratom at least once and 1% said they used it in the last year. The share of children ages 12 and older who said they had used kratom increased from 1.6% in 2021 to 1.9% in 2024.
The FDA has stated that neither kratom nor 7-OH are approved as drug products, dietary supplements or food additives, but that hasn’t stopped storefronts and companies from selling them as such.
Up until November you could find kratom and 7-OH products in smoke shops and specialty stores in California, but that has stopped.
“Until kratom and its pharmacologically active key ingredients mitragynine and 7-OH are approved for use, they will remain classified as adulterants in drugs, dietary supplements and foods,” the California Department of Public Health told The Times via email.
Kratom “Feel Free Classic” liquid products are displayed at a smoke shop in Los Angeles in 2024 before they were banned.
(Michael Blackshire / Los Angeles Times)
In May, the California Department of Public Health and Atty. Gen. Rob Bonta filed a complaint against Ashlynn Marketing Group Inc., accusing the company of repeatedly flouting the state’s regulations on kratom products.
The filing, submitted in the San Diego County Superior Court, seeks a judge’s order to condemn and destroy the embargoed kratom products, halt ongoing unlawful manufacturing and impose civil penalties.
The California Department of Public Health “is pursuing legal action because Ashlynn’s continued manufacture and sale of these products pose a clear and preventable public‑health risk and violates state and federal law,” said Dr. Erica Pan, the department’s director and state public health officer. “7-OH and kratom-derived products have been associated with addiction, serious health harms, overdose and death.”
The state is alleging its inspectors visited Ashlynn Marketing Group’s facility in Santee in May 2025 and found kratom powders, capsules, liquids and chewable tablets being manufactured and held for sale.
During the visit, inspectors issued an embargo to prohibit the sale and distribution of all kratom-related materials on-site, according to the complaint.
Public health inspectors conducted follow-up visits at the facility in October and April, “collecting evidence at both inspections that indicated embargoed kratom products had been moved, tampered with and repackaged,” according to public health officials.
“In addition, investigators observed evidence of continued manufacturing and distribution of kratom materials,” officials said. “The firm’s owner continues to manufacture kratom products and ships orders weekly.”
To date, the California Department of Public Health has seized more than $5 million worth of kratom and 7-OH products, a spokesperson for the department told The Times.
California and Los Angeles County are considering whether to tighten regulations or ban the compounds altogether.
Science
Scientists find a whale graveyard in the Indian Ocean that’s millions of years old
NEW YORK — Scientists have unearthed communities of marine life — including jellyfish, tubeworms and brittle stars — thriving on a whale graveyard that is millions of years old.
These graveyards form when whale carcasses fall to the sea floor, becoming a sustaining snack for nearby critters. This one, located up to 23,000 feet below the surface of the southeastern Indian Ocean, spans the largest area and is so far the deepest and oldest found.
A whale’s sheer size and the unique chemistry of its bones are the keys to forming these unique underwater neighborhoods, said Xikun Song, a biologist with the Chinese Academy of Sciences’ Institute of Deep-sea Science and Engineering.
“At the same time, the very nature of the deep ocean makes these sites exceptionally difficult for scientists to locate,” Song, who was involved with the latest find, wrote in an email.
Researchers explored the remains during multiple deep-sea submersible trips in 2023, collecting samples and mapping the extent of the necropolis. They found five carcass sites and fossils, including skulls belonging to beaked and baleen whales. The oldest bones date back 5.3 million years.
Feeding and living on the carcasses were myriad creatures, large and small, including sea cucumbers, squat lobsters and saltwater clams. Many of them are likely species that have never been documented, according to findings published Wednesday in the journal Nature.
“The potential number of specimens is just astounding,” said paleontologist Stephen Godfrey with the Calvert Marine Museum in Maryland, who wasn’t involved in the research.
Many factors likely conspired to preserve the bones for millions of years, according to the study authors. They’re dense enough to outlast attacks from bone-eating worms, and located deep enough in the ocean to avoid getting buried by dust and loose particles. The bones also were coated with a light layer of minerals from the surrounding seawater, which may have prevented them from degrading.
Why did so many whales die here? Maybe they were already living in the area and died of natural causes. A few could have perished from exhaustion or illness caused by deep-sea diving. The area’s shape, akin to the letter V, could also have funneled the remains to their resting spot, the authors wrote.
Such discoveries are important because they clue scientists into the vibrant communities that find a way to live even in remote, hard-to-reach environments.
Studying the whale graveyards “is important for understanding how life can adapt to such extreme conditions, not only due to the lack of light and oxygen but also to the incredibly high pressure,” said study co-author and paleontologist Giovanni Bianucci with the University of Pisa in Italy in an email.
Ramakrishnan writes for The Associated Press.
The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education and the Robert Wood Johnson Foundation.
-
Vermont6 minutes agoVt. communities work to clean up after EF-1 tornadoes strike
-
Washington9 minutes agoIMPD adds third public safety camera along Washington St in three months
-
Virginia9 minutes agoVirginia Lottery Mega Millions, Pick 3 Night results for June 19, 2026
-
Wisconsin21 minutes ago
Wisconsin Lottery Mega Millions, Pick 3 results for June 19, 2026
-
West Virginia24 minutes agoStories of the Week: June 14 through June 20
-
Wyoming36 minutes ago$1 million Wyoming home sale among the week’s top property transfers
-
Crypto39 minutes agoIreland Targets Crypto Assets in New Strategy to Disrupt Illicit Cash Flows
-
Finance44 minutes agoFinancial adviser warns, ‘stay away from the hype’ of an IPO